Mij
Senior Member (Voting Rights)
Abstract
We investigated if children with Long Covid (n=14) have activated platelets compared with healthy controls (n=14). Platelet activation and secretion markers were investigated by flow cytometry using MoAbs directed against P-selectin, CD63, and PAC-1 in quiescent platelets and in platelets stimulated with 10-µM adenosine diphosphate and 25-µM protease activated receptor 1-activating peptide. Circulating platelets of patients with Long Covid had significantly increased expression of the activation marker cytometry using MoAbs directed against P-selectin (P = 0.019).
BACKGROUND
Long Covid is a condition characterized by persisting symptoms several weeks after COVID-19. In adults with this condition, hypercoagulability, endotheliopathy, and thromboinflammation with complement dysregulation have been demonstrated and considered pathogenetic mechanisms.1,2 In addition, persistent activation of circulating platelets was demonstrated in adults 1 year after COVID,3 possibly expression of immune dysregulation and persistent inflammation triggered by the initial infection.1–3
About the pediatric population, observational studies have demonstrated that children also can develop Long Covid. A recent state-of-the-art narrative review showed how children can present persistent symptoms from acute SARS-CoV-2 infection (eg, cough, headaches, fatigue, and loss of taste and smell), new symptoms such as dizziness, or exacerbation of underlying conditions, or develop conditions de novo, including postural orthostatic tachycardia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune conditions, and multisystem inflammatory syndrome in children.4 Although these symptoms tend usually to improve over time, studies have found that children can suffer from Long Covid for ≥18 months,4 therefore having a significant impact on daily life.
Although Long Covid has been documented in children as well, no studies have investigated the pathogenetic mechanisms of the disease in this population. Given the growing evidence of ongoing thromboinflammation in adults with Long Covid,4 we performed this study aiming to explore if activated platelets are more expressed in children with Long Covid compared with controls, as a possible indirect sign of endothelial inflammation.
LINK
We investigated if children with Long Covid (n=14) have activated platelets compared with healthy controls (n=14). Platelet activation and secretion markers were investigated by flow cytometry using MoAbs directed against P-selectin, CD63, and PAC-1 in quiescent platelets and in platelets stimulated with 10-µM adenosine diphosphate and 25-µM protease activated receptor 1-activating peptide. Circulating platelets of patients with Long Covid had significantly increased expression of the activation marker cytometry using MoAbs directed against P-selectin (P = 0.019).
BACKGROUND
Long Covid is a condition characterized by persisting symptoms several weeks after COVID-19. In adults with this condition, hypercoagulability, endotheliopathy, and thromboinflammation with complement dysregulation have been demonstrated and considered pathogenetic mechanisms.1,2 In addition, persistent activation of circulating platelets was demonstrated in adults 1 year after COVID,3 possibly expression of immune dysregulation and persistent inflammation triggered by the initial infection.1–3
About the pediatric population, observational studies have demonstrated that children also can develop Long Covid. A recent state-of-the-art narrative review showed how children can present persistent symptoms from acute SARS-CoV-2 infection (eg, cough, headaches, fatigue, and loss of taste and smell), new symptoms such as dizziness, or exacerbation of underlying conditions, or develop conditions de novo, including postural orthostatic tachycardia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune conditions, and multisystem inflammatory syndrome in children.4 Although these symptoms tend usually to improve over time, studies have found that children can suffer from Long Covid for ≥18 months,4 therefore having a significant impact on daily life.
Although Long Covid has been documented in children as well, no studies have investigated the pathogenetic mechanisms of the disease in this population. Given the growing evidence of ongoing thromboinflammation in adults with Long Covid,4 we performed this study aiming to explore if activated platelets are more expressed in children with Long Covid compared with controls, as a possible indirect sign of endothelial inflammation.
LINK